Skip to main content

Advertisement

SpringerLink
Log in

Predictors of subsequent primary melanoma: a case–control study

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Patients with history of malignant melanoma (MM) are at risk of developing subsequent primary MM (SPM). Predictors of SPM may be helpful to identify patients at higher risk. The objective of the study is to investigate the phenotypic traits, indirect actinic exposure features and pathological variables associated with the risk of development of SPM. A ten-year retrospective case–control study was undertaken involving patients following MM excision who underwent regular video-dermoscopic examination at 4—6-month intervals for the first 5 years, followed by annual dermoscopic examination for the following five years. Patients with only one primary cutaneous MM were compared with those who developed at least one SPM. A total of 577 patients were included, 309 (53.6%) men and 268 (46.5%) women (mean age, 55 ± 15 years), comprising 450 patients with single melanoma and 127 with at least one SPM. The median time span to the SPM was 30 (IQR 12–53) months. Compared to the first melanoma, SPM were thinner, mean Breslow 0.56 ± 0.64 mm vs 1.37 ± 1.83 mm (p < 0.001); in situ MM prevalence 12% vs 36% (p < 0.001). 36 % of the patients with SPM developed it in the anatomical site of the previous melanoma. At multivariate analysis, having numerous naevi (i.e. 10–50 nevi) OR = 2.88 (95% CI 1.32–6.28, previous dysplastic naevi excisions OR = 2.51 (95% CI 1.53–4.12), solar lentigo OR = 2.68 (95% CI 1.67–4.31) and actinic keratosis OR = 3.09 (95% CI 1.64–4.31) were associated with an increased risk of SPM. These features may identify persons at increased risk of developing SPM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Welch HG, Mazer BL, Adamson AS (2021) The rapid rise in cutaneous melanoma diagnoses. N Engl J Med 384:72–79

    Article  Google Scholar 

  2. Pflugfelder A, Kochs C, Blum A et al (2013) German Dermatological Society; Dermatologic Cooperative Oncology Group. Malignant melanoma S3-guideline “diagnosis, therapy and follow-up of melanoma.” J Dtsch Dermatol Ges 11:1–126

    PubMed  Google Scholar 

  3. Bichakjian CK, Halpern AC, Johnson TM et al (2011) American Academy of Dermatology. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 65:1032–1047

    Article  Google Scholar 

  4. Johnson TM, Hamilton T, Lowe L (1998) Multiple primary melanomas. J Am Acad Dermatol 39:422–427

    Article  CAS  Google Scholar 

  5. DiFronzo LA, Wanek LA, Morton DL (2001) Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up. Cancer 91:1520–1524

    Article  CAS  Google Scholar 

  6. Youlden DR, Baade PD, Soyer HP, Youl PH, Kimlin MG, Aitken JF, Green AC, Khosrotehrani K (2016) Ten-year survival after multiple invasive melanomas is worse than after a single melanoma: a population-based study. J Invest Dermatol 136:2270–2276

    Article  CAS  Google Scholar 

  7. Bradford PT, Freedman DM, Goldstein AM, Tucker MA (2010) Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 146:265–272

    Article  Google Scholar 

  8. Siskind V, Hughes MC, Palmer JM, Symmons JM, Aitken JF, Martin NG et al (2011) Nevi, family history, and fair skin increase the risk of second primary melanoma. J Invest Dermatol 131:461–467

    Article  CAS  Google Scholar 

  9. Bower MR, Scoggins CR, Martin RC 2nd, Mays MP, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Noyes RD, Sussman JJ, Hagendoorn LJ, Stromberg AJ, McMasters K (2010) Second primary melanomas: incidence and outcome. Am Surg 76:675–681

    Article  Google Scholar 

  10. Hwa C, Price LS, Belitskaya-Levy I, Ma MW, Shapiro RL, Berman RS et al (2012) Single versus multiple primary melanomas: old questions and new answers. Cancer 118:4184–4192

    Article  Google Scholar 

  11. Jones MS, Torisu-Itakura H, Flaherty DC, Schoellhammer HF, Lee J, Sim MS et al (2016) Second primary melanoma: risk factors, histopathologic features, survival, and implications for follow-up. Am Surg 82:1009–1013

    Article  Google Scholar 

  12. Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM (2019) Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol 80:303–317 (J Am Acad Dermatol 2021 85 535)

    Article  Google Scholar 

  13. Giles G, Staples M, McCredie M, Coates M (1995) Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Melanoma Res 5:433–438

    Article  CAS  Google Scholar 

  14. Moore MM, Geller AC, Warton EM, Schwalbe J, Asgari MM (2015) Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. J Am Acad Dermatol 73:630–636

    Article  Google Scholar 

  15. Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W (2001) Multiple primary melanomas. J Am Acad Dermatol 44:22–27

    Article  CAS  Google Scholar 

  16. Krajewski AC, Hart DR, Hieken TJ (2016) Multiple primary melanoma in the elderly. Am J Surg 211:84–88

    Article  Google Scholar 

  17. de Giorgi V, Rossari S, Papi F, Gori A, Alfaioli B, Grazzini M et al (2010) Multiple primary melanoma: the impact of atypical naevi and follow up. Br J Dermatol 163:1319–1322

    Article  Google Scholar 

  18. Pastor-Tomás N, Martínez-Franco A, Bañuls J, Peñalver JC, Traves V, García-Casado Z et al (2020) Risk factors for the development of a second melanoma in patients with cutaneous melanoma. J Eur Acad Dermatol Venereol 34:2295–2302

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Section of Dermatology and Venereology, Department of Medicine, University of Verona, Piazzale A. Stefani 1, 37126, Verona, Italy

    Francesco Bellinato, Paolo Rosina, Beatrice Tonin, Paolo Gisondi & Giampiero Girolomoni

Authors
  1. Francesco Bellinato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paolo Rosina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beatrice Tonin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paolo Gisondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giampiero Girolomoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Bellinato.

Ethics declarations

Conflict of interest

F Bellinato, P Rosina, B Tonin, P Gisondi, G Girolomoni: none.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bellinato, F., Rosina, P., Tonin, B. et al. Predictors of subsequent primary melanoma: a case–control study. Arch Dermatol Res 314, 881–885 (2022). https://doi.org/10.1007/s00403-021-02309-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-021-02309-9

Keywords

Search

Navigation